|
Amarin Falls as Investors Await Drug’s Exclusivity Decision
Amarin Corp. (AMRN), maker of the blood-fat drug Vascepa (icosapent ethyl), fell the most in two weeks after the company said U.S. regulators hadn’t determined whether to grant the medicine five-year marketing exclusivity.
Bloomberg |
Register Now
Archives